ProShare Advisors LLC

Position in MGTX — MeiraGTx Holdings plc

CIK 1357955 BETHESDA, MD

Position in MGTX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$87,950

-$5,701 QoQ

Shares Held

10,156

-13.8% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ProShare Advisors LLC holds $466,757,935 across 164 Biotechnology names. MGTX ranks #134 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	373,532	$166,796,979
2	REGN	Regeneron Pharmaceuticals, Inc.	152,397	$117,748,018
3	ALNY	Alnylam Pharmaceuticals, Inc.	174,013	$57,575,681
4	INSM	INSMED Inc	283,141	$46,299,216
5	INCY	Incyte Corp	49,678	$4,675,693
6	MRNA	Moderna, Inc.	71,342	$3,624,173
7	BBIO	BridgeBio Pharma, Inc.	31,677	$2,352,334
8	ARWR	Arrowhead Pharmaceuticals, Inc.	31,498	$1,974,924

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$87,950	10,156	-13.8%	Shares	Sole	2026-04-27
2025-12-31	$93,651	11,780	+2.0%	Shares	Sole	2026-02-06
2025-06-30	$75,279	11,546	-15.9%	Shares	Sole	2025-08-07
2025-03-31	$93,089	13,730	-18.3%	Shares	Sole	2025-05-08
2024-12-31	$102,397	16,814	+41.2%	Shares	Sole	2025-02-14
2024-09-30	$49,639	11,904	+15.4%	Shares	Sole	2024-11-14
2024-03-31	$62,612	10,315	+1.3%	Shares	Sole	2024-05-08
2022-03-31	$141,076	10,186	-20.2%	Shares	Sole	2022-05-10
2021-12-31	$302,946	12,761	-3.9%	Shares	Sole	2022-02-08
2021-09-30	$175,096	13,285	-15.3%	Shares	Sole	2021-11-12
2021-06-30	$243,102	15,684	+26.7%	Shares	Sole	2021-08-13
2021-03-31	$178,672	12,382	+8.9%	Shares	Sole	2021-05-14
2020-12-31	$172,217	11,375	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.